Showing 35,658 results

Drug interactions & pharmacokinetics

HIV-treatment 'booster drugs' are most likely to have dangerous interactions with methamphetamine, mephedrone, MDMA and ketamine

News
24 August 2015
Transgender people

Trans health care in the USA: a long way to go

Editor's pick
The Lancet
21 August 2015
Pharmaceutical industry

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Editor's pick
Gilead press release
21 August 2015
How HIV works

How long have primates been infected with viruses related to HIV?

Editor's pick
Eurekalert Inf Dis
21 August 2015
Bad science & bogus treatments

Interview with HIV denier-turned-science-advocate John Strangis

Editor's pick
ScienceBlogs
21 August 2015
Condoms & lubricant

Ugandan gay men talk about why they do not always use condoms

News
21 August 2015
Sex workers

Meeting the Drug-Addicted Male Escorts Pressured to Take Mephedrone and GHB at Chemsex Parties

Editor's pick
Vice
20 August 2015
PrEP

PrEPosterous gender health inequality?

Editor's pick
NAT
20 August 2015
History of HIV & AIDS

ACON: Here for health and HIV for 30 years

Editor's pick
Gay News Network
20 August 2015
Prisoners

The missing link in new US AIDS strategy

Editor's pick
The Hill
20 August 2015
History of HIV & AIDS

It's Time to Retire the Medical Category of AIDS

Editor's pick
The Body
20 August 2015
Global health initiatives

New site details how PEPFAR funding is spent

Editor's pick
Science Speaks
20 August 2015
New & experimental HIV treatments

'Tweezer' molecule can block HIV in semen, study says

Editor's pick
RT.com
19 August 2015
Retention & linkage to care

Namibia: Kids Eat ARVs Discarded By HIV Patients

Editor's pick
AllAfrica.com
19 August 2015
PrEP

AIDS Healthcare Foundation Cedes Ground in Anti-PrEP Fight

Editor's pick
AIDSMeds
19 August 2015
People who inject drugs

While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

Editor's pick
National Journal
19 August 2015
Pharmaceutical industry

After Curing Hepatitis C, Gilead Works to Vanquish More Viruses

Editor's pick
Bloomberg
19 August 2015
Retention & linkage to care

HIV-positive postpartum women who rapidly re-engage with HIV care more likely to have viral suppression in longer term

News
19 August 2015

HIV update - 19th August 2015

August 2015
New & experimental hepatitis C treatment

Hepatitis C patients in England denied lifesaving liver drug

Editor's pick
The Observer
18 August 2015
Undetectable viral load & treatment as prevention

Targeting HIV in semen to shut down AIDS

Editor's pick
Eurekalert Medicine & Health
18 August 2015
Undetectable viral load & treatment as prevention

Study suggests Ontario nearing U.N. targets to help end AIDS epidemic

Editor's pick
St Michael's Hospital press release
18 August 2015
Retention & linkage to care

Low rates of engagement with HIV care among women who have recently given birth in Cape Town townships

News
18 August 2015
The search for a cure

HIV cure research today: Gene therapy, molecular scissors and Where’s Waldo

Editor's pick
Fred Hutch News Service
18 August 2015